High-dose intravenous cyclophosphamide therapy in severe SLE

D’Cruz, David

doi:10.1191/0961203302lu232ed

Lupus

2002

DOI: 10.1191/0961203302lu232ed

|View full text |Cite

High-dose intravenous cyclophosphamide therapy in severe SLE

David D’Cruz

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2011

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Highdose IV cyclophosphamide therapy has resulted in significant improvements in this potentially life-threatening disease (Dussán, Magder, Brodsky, Jones, & Petri, 2008). Dosages may be based on milligrams per kilogram, not on body surface area (D'Cruz, 2002).…”

mentioning

confidence: 99%

Administering Chemotherapy in Nononcology Settings: A Case Study

Smith¹

2011

Clinical Journal of Oncology Nursing

View full text Add to dashboard Cite

Providing chemotherapy for patients in a variety of settings may be a challenge for oncology nurses. Increased acuity and comorbidities of patients needing chemotherapy have resulted in a greater incidence of administration in nononcology settings, such as intensive care units (ICUs). In addition, patients with conditions other than cancer are receiving chemotherapy. Because of a lack of certified and experienced chemotherapy nurses in the ICU, oncology nurses may be pulled from their unit to administer chemotherapy. Another possibility is that nonchemotherapy-certified nurses may be asked to administer chemotherapy. Caring for patients receiving chemotherapy may be stressful for nononcology nurses because of their lack of knowledge regarding chemotherapy precautions and the management of side effects and toxicities. Not only is coordination and cooperation between nursing personnel vital, certified oncology nurses must be able to assess the situation, provide the necessary information and education, and safely administer the chemotherapy. This article describes a case study and provides suggestions for planning in similar situations.

show abstract

mentioning

confidence: 99%

Administering Chemotherapy in Nononcology Settings: A Case Study

Smith¹

2011

Clinical Journal of Oncology Nursing

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

High-dose intravenous cyclophosphamide therapy in severe SLE

Cited by 1 publication

References 9 publications

Administering Chemotherapy in Nononcology Settings: A Case Study

Administering Chemotherapy in Nononcology Settings: A Case Study

Contact Info

Product

Resources

About